Lutalyse en es it fr

Lutalyse Brand names, Lutalyse Analogs

Lutalyse Brand Names Mixture

  • No information avaliable

Lutalyse Chemical_Formula

C23H36O3

Lutalyse RX_link

No information avaliable

Lutalyse fda sheet

Lutalyse msds (material safety sheet)

Lutalyse Synthesis Reference

No information avaliable

Lutalyse Molecular Weight

360.53 g/mol

Lutalyse Melting Point

128 oC

Lutalyse H2O Solubility

No information avaliable

Lutalyse State

Solid

Lutalyse LogP

4.566

Lutalyse Dosage Forms

Solution for injection

Lutalyse Indication

For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.

Lutalyse Pharmacology

Dromostanolone is a synthetic androgen, or male hormone, similar to testosterone. Dromostanolone works by attaching itself to androgen receptors; this causes it to interact with the parts of the cell involved in the making of proteins. It may cause an increase in the synthesis of some proteins or a decrease in the synthesis of others. These proteins have a variety of effects, including blocking the growth of some types of breast cancer cells, stimulating cells that cause male sexual characteristics, and stimulating the production of red blood cells.

Lutalyse Absorption

Well absorbed following parenteral administration.

Lutalyse side effects and Toxicity

Side effects include virilization (masculine traits in women), acne, fluid retention, and hypercalcemia.

Lutalyse Patient Information

No information avaliable

Lutalyse Organisms Affected

Humans and other mammals